Pharmacologic Disruption: How Emerging Weight Loss Therapies Are Challenging Bariatric Surgery Guidelines

Pharmacologic Disruption: How Emerging Weight Loss Therapies Are Challenging Bariatric Surgery Guidelines

Obesity is a chronic, relapsing disease with multifactorial origins and significant global health implications. Historically, bariatric surgery has been the most effective intervention for achieving sustained weight loss and metabolic improvement, especially in individuals with moderate to severe ob...

Full description

Saved in:
Bibliographic Details
Main Authors: Safi G. Alqatari, Abrar J. Alwaheed, Manal A. Hasan, Reem J. Al Argan, Marj M. Alabdullah, Mohammed D. Al Shubbar
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Medicina
Subjects:
anti-obesity agents
bariatric surgery
obesity
weight loss medications
glucagon-like peptide 1
Online Access:https://www.mdpi.com/1648-9144/61/7/1292
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items